Lunit acquires Volpara to enhance AI-driven breast cancer care
Lunit will integrate Volpara's breast health platform with AI-powered solutions for cancer detection. The acquisition also enables expansion into new markets.
Health AI
JLK to supply healthcare AI solutions for stroke detection to Siloam Hospitals in Indonesia
JLK will supply Siolam Hospitals with healthcare AI solutions that include JLK-ICH and JLK-UIA for detecting brain haemorrhages and brain aneurysms, respectively.
Department of Health – Abu Dhabi, MBZUAI, and Core42 launch Global AI Healthcare Academy in UAE
A new academy will cover topics including AI for radiology and cardiology, aside from advanced data analytics and prediction techniques.
Indonesia’s Ministry of Health and Google Cloud partner to improve patient outcomes
A collaboration between Kementerian Kesehatan and Google Cloud lays the foundation for generative AI solutions while maintaining patient data privacy and security.
King Faisal Specialist Hospital & Research Centre aims to enhance patient outcomes with AI
KFSH&RC's ANFAL AI system, designed to enhance the patient experience, is among several healthcare innovations embarked on by the Riyadh hospital.
MBZUAI collaborates with Indonesian and Oxford teams for healthcare AI research
Abu Dhabi-based Mohamed bin Zayed University of Artificial Intelligence is developing AI-powered applications to help reduce the impact of malaria in Indonesia.
Microsoft’s AI investment in Malaysia poised to drive healthcare innovation
Microsoft has unveiled plans to inject US$2.2 billion into Malaysia over the next four years, with healthcare standing to benefit.
Lunit partners with Radiobotics to enhance AI-assisted X-ray screening
RBfracture used with Lunit’s AI-powered chest X-ray screening solution, Lunit INSIGHT CXR, will enhances the diagnostic capabilities available to providers.
Gen AI addressing ‘pressing challenges’ in Saudi healthcare
Saudi Arabia's Minister of Communications and Information Technology highlighted the use of generative AI in tackling hereditary sickle cell disease.